Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
18.05
0.00 (0.00%)
Aug 13, 2025, 4:00 PM - Market open
Travere Therapeutics Market Cap
Travere Therapeutics has a market cap or net worth of $1.61 billion as of August 14, 2025. Its market cap has increased by 107.39% in one year.
Market Cap
1.61B
Enterprise Value
1.69B
1-Year Change
107.39%
Ranking
Category
Stock Price
$18.05
Market Cap Chart
Since December 31, 2012, Travere Therapeutics's market cap has increased from $40.40M to $1.61B, an increase of 3,882.56%. That is a compound annual growth rate of 33.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 1.61B | 18.34% |
| Dec 31, 2024 | 1.36B | 101.24% |
| Dec 29, 2023 | 675.60M | -49.94% |
| Dec 30, 2022 | 1.35B | -28.99% |
| Dec 31, 2021 | 1.90B | 36.59% |
| Dec 31, 2020 | 1.39B | 128.10% |
| Dec 31, 2019 | 610.00M | -34.65% |
| Dec 31, 2018 | 933.40M | 12.70% |
| Dec 29, 2017 | 828.20M | 15.95% |
| Dec 30, 2016 | 714.30M | 2.44% |
| Dec 31, 2015 | 697.30M | 113.37% |
| Dec 31, 2014 | 326.80M | 153.92% |
| Dec 31, 2013 | 128.70M | 218.56% |
| Dec 31, 2012 | 40.40M | - |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |